Sarcoidosis drug dilemma: stop or stay? new trial seeks answer
NCT ID NCT05689879
First seen Feb 04, 2026 · Last updated May 22, 2026 · Updated 19 times
Summary
This study looks at adults with sarcoidosis who are in remission after taking the drug infliximab. It compares two strategies: stopping the drug versus continuing it, to see which better prevents the disease from coming back. The goal is to find the best way to keep patients healthy long-term.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SARCOIDOSIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Hôpital de la Pitié-Salpêtrière
Paris, 75013, France
Conditions
Explore the condition pages connected to this study.